Ronald McCaughan
Vorstandsvorsitzender bei Noninvasive Medical Technologies, Inc.
Profil
Ronald McCaughan is currently the Chairman & Chief Executive Officer at Noninvasive Medical Technologies, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Noninvasive Medical Technologies, Inc.
 Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. inf% | 09.02.2007 | 1 190 476 ( inf% ) | - $ | Heute |
Aktive Positionen von Ronald McCaughan
| Unternehmen | Position | Beginn |
|---|---|---|
Noninvasive Medical Technologies, Inc.
Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Noninvasive Medical Technologies, Inc.
Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. | Health Technology |